Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631851 · ClinicalTrials.gov registry record · NA
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01631851 is a NA study that has completed, run by Yale University. The registered enrollment target is 9 participants.
The verdict
NCT01631851, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
In addition to the core symptoms, children and adolescents with Autism Spectrum Disorder (ASD) often exhibit disruptive behavior problems including irritability, tantrums, noncompliance, and aggression. This is a pilot study of Cognitive-Behavioral Therapy, also known as Anger Control Training, in adolescents with high-functioning ASD. CBT teaches children to recognize antecedents and consequences of problem behavior and to use emotion regulation and problem-solving skills to reduce irritability, aggression and noncompliance. This form of CBT has been well-studied in typically developing children with disruptive behavior and we are investigating if this treatment can be feasible and helpful, with appropriate modifications, for irritability and disruptive behavior in ASD.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy (CBT) for Irritability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01631851
The ClinicalTrials.gov registry entry for NCT01631851 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive-Behavioral Therapy (CBT) for Irritability is the first listed.
NCT01631851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01631851 about?
NCT01631851 is a clinical study titled "Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder". In addition to the core symptoms, children and adolescents with Autism Spectrum Disorder (ASD) often exhibit disruptive behavior problems including irritability, tantrums, noncompliance, and aggression. This is a pilot study of Cognitive-Behavioral Therapy, also known as Anger Control Training, in a...
What is the current status of trial NCT01631851?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2011-05. Estimated completion is 2013-04-23.
What interventions are being tested in trial NCT01631851?
The interventions under investigation include: Cognitive-Behavioral Therapy (CBT) for Irritability (BEHAVIORAL).
Who is sponsoring clinical trial NCT01631851?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.